ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children
July 14, 2021Micron Biomedical, Inc. ("Micron" or the "Company"), a leader in dissolving, microneedle-based vaccine and drug delivery, today announced that it has initiated a Phase 1/2 clinical trial of its microneedle-based measles-rubella ("MR") vaccine. -
Micron Progresses with Clinical Evaluation of Measles-Rubella Vaccination Technology
September 03, 2020Micron Biomedical recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation.
Pharma Sources Insight January 2025
